Skip to main content
Log in

Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

Incidence and risk factors

  • Liver: Cirrhosis, Fibrosis, Portal Hypertension, And Transplantation
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Forty-seven consecutive patients were prospectively evaluated to study the incidence of hepatic encephalopathy as well as modifications in the PSE index after TIPS. Various clinical, laboratory, and angiographic parameters were also recorded to identify risk factors for the development of post-TIPS hepatic encephalopathy (HE). Mean follow-up was 17±7 months. During follow-up, six patients died and one underwent transplantation. All other patients were followed for at least a year. Fifteen patients (32%) experienced 20 acute episodes of precipitated HE (hospitalization was necessary in 10 instances), and five patients (11%) presented a continuous alteration in mental status with frequent spontaneous exacerbation during follow-up. Both precipitated and spontaneous HE occurred more frequently during the first three months of follow-up. Moreover the PSE index was significantly worse than basal values one month after TIPS, thereafter returning to near basal values. HE was successfully treated in all patients but one who required a reduction in the stent/shunt diameter. Increasing age (>65 years) and low portacaval gradient (<10 mm Hg) were predictors of HE after TIPS. A gradual dilation of the stent/shunt should be performed to obtain a portacaval gradient >10 mm Hg to avoid an unacceptable rate of HE after TIPS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sanyal AJ, Freedman AM, Shiffman ML, Purdumm PP, Luketic VA, Tisnado J, Cole P, Cheatman A: Transjugular intrahepatic portosystemic shunt (TIPS) for uncontrolled variceal haemorrhage in advanced cirrhotics at high risk for surgery. A prospective study. Gastroenterology 104:A985, 1993 (abstract)

    Google Scholar 

  2. McCormick PA, Dick R, Panagou EB, Chin JKT, Greenslade L, McIntyre N, Burroughs AK: Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg 81:1324–1327, 1994

    Google Scholar 

  3. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM, Berger E, et al: The transjugular intrahepatic portasystemic stent-shunt procedure for variceal bleeding. N Engl J Med 330:165–171, 1994

    Google Scholar 

  4. Ochs A, Rossle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, et al: The transjugular intrahepatic portasystemic stent-shunt procedure for refractory ascites. N Engl J Med 332:1192–1197, 1995

    Google Scholar 

  5. Ochs A, Sellinger M, Haag K, Noldge G, Herbst EW, Walter E, Gerok W, Rossle M: Transjugular intrahepatic portasystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 18:217–225, 1993

    Google Scholar 

  6. Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE, Sterneck MR, et al: Using transjugular intrahepatic portasystemic shunt to control variceal bleeding before liver transplantation. Ann Intern Med 116:304–309, 1992

    Google Scholar 

  7. Sanyal AJ, Freedman AM, Purdumm PP, Luketic VA, Shiffman ML, Tisnado J, Cole P: Transjugular intrahepatic portosystemic shunt (TIPS) vs sclerotherapy for prevention of recurrent variceal haemorrhage: A randomized prospective study. Gastroenterology 106:A975, 1994 (abstract)

    Google Scholar 

  8. Merli M, Riggio O, Capocaccia L, Ziparo V, Bolognese A, Rossi P, Salerno F, et al: Transjugular intrahepatic portosystemic shunt (TIPS) vs endoscopic sclerotherapy in preventing variceal rebleeding. Preliminary results of a randomized controlled trial. Hepatology 20:107A, 1994 (abstract)

    Google Scholar 

  9. Rossle P, Deibert P, Haag K, Ochs A, Siegerstetter V, Langer M: TIPS vs sclerotherapy and β-blockade: Preliminary results of a randomized study in patients with recurrent variceal haemorrhage. Hepatology 20:107A, 1994 (abstract)

    Google Scholar 

  10. Cabrera J, Maynar M, Granados R, Gorriz E, Presa F, Reyes R, Pulido-Duque JM et al: Transjugular intrahepatic portosystemic shunt (TIPS) vs sclerotherapy in the elective treatment of variceal bleeding. Hepatology 20:203A, 1994 (abstract)

  11. Lind CD, Malish TW, Chong WK, Richards WO, Wrigt Pinson C, Meranze SG, Mazer M: Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology 106:1277–1283, 1994

    Google Scholar 

  12. Conn HO: Portal-systemic encephalopathy (PSE) after transjugular intrahepatic portasystemic stent-shunt (TIPS). Ital J Gastroenterol 25:397–399, 1993

    Google Scholar 

  13. Sanyal AJ, Freedman AM, Shiffman ML, Purdumm PP, Luketic VA, Cheatham AK: Portosystemic encephalopathy after transjugular intrahepatic portasystemic shunt: result of a prospective controlled study. Hepatology 20:46–55, 1994

    Google Scholar 

  14. Rossi P, Ricci P, Natali G, Pizzi G, Orsi F, Panzetti C, Rossi M, et al: Derivazione porto-sistemica intraepatica transjugulare (TIPS): aspetti tecnici. Radiologia Medica 87:577–584, 1994

    Google Scholar 

  15. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seef L, Levy LL: Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. Gastroenterology 72:573–583, 1977

    Google Scholar 

  16. Mutchnick MG, Lerner E, Conn HO: Porto-systemic encephalopathy and portacaval anastomosis: a prospective controlled investigation. Gastroenterology 66:1005–1019, 1974

    Google Scholar 

  17. Eriksson LS: Hepatic encephalopathy and treatment of oesofageal varices. Scan J Gastroenterol 23:641–649, 1988

    Google Scholar 

  18. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL: Creation of transjugular intrahepatic portasystemic shunt with the Wallstent endoprotesis: results in 100 patients. Radiology 187:413–420, 1993

    Google Scholar 

  19. Helton WS, Belshaw A, Althaus S, Park S, Coldwell D, Johanson K: Critical appraisal of the angiografic portacaval shunt (TIPS). Am J Surg 165:566–571, 1993

    Google Scholar 

  20. Sellinger M, Haag K, Ochs A, Noeldge G, Gerok W, Rossle M. Factors influencing the incidence of hepatic encephalopathy in patients with transjugular intrahepatic portasystemic stentshunt (TIPS). Hepatology 16:122A, 1992 (abstract)

  21. Somberg KA, Riegler JL, Doherty M, LaBerge JM, Bachetti P, Roberts JP, Lake JR: Hepatic encephalopathy following transjugular intrahepatic portasystemic shunt (TIPS): Incidence and risk factors. Hepatology 16:122A, 1992 (abstract)

    Google Scholar 

  22. Jalan R, Elton RA, Redhead DN, Finlayson NDC, Hayes PC: Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 23:123–128, 1995

    Google Scholar 

  23. Groszman RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, Alberts J: Hemodynamic events in a prospective randomized trial of propanolol vs placebo in the prevention of a first variceal hemorrhage. Gastroenterology 99:1401–1407, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riggio, O., Merli, M., Pedretti, G. et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Digest Dis Sci 41, 578–584 (1996). https://doi.org/10.1007/BF02282344

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02282344

Key words

Navigation